NRC Health Analyst Price Targets

NRC Health

NRCNASDAQ

Trade with Public

$20.47

0.321.59%

마지막 업데이트: Oct 19, 4:00 PM

$20.47

0.321.59%

개요 뉴스 실적 전망목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

NRC Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for NRC Health (NRC).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1S.Buy

Consensus RatingMarket Outperform# Analysts1Avg. Consensus PT$26Upside to Avg. PT+27.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 29, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$23→$26
Jun 22, 2026	Citizens	Constantine Davides	Initiate	Market Outperform	$23

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $23 to $26.

Benzinga Newsdesk

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

Citizens analyst Constantine Davides initiates coverage on NRC Health (NASDAQ:NRC) with a Market Outperform rating and announces Price Target of $23.

Benzinga Newsdesk

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Benzinga

Williams Capital Research Comments on SCANA Corporation

Benzinga

Rodman & Renshaw Maintains Market Outperform, PT

Benzinga

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

Benzinga

NRC Health

NRC Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Williams Capital Research Comments on SCANA Corporation

Rodman & Renshaw Maintains Market Outperform, PT

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

뉴스

파트너 / 기고자

벤징가 글로벌

NRC Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Williams Capital Research Comments on SCANA Corporation

Rodman & Renshaw Maintains Market Outperform, PT

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

People Also Watch

People Also Watch

NRC Health

NRC Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCitizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PROCitizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Williams Capital Research Comments on SCANA Corporation

Rodman & Renshaw Maintains Market Outperform, PT

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

뉴스

파트너 / 기고자

벤징가 글로벌

NRC Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCitizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PROCitizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Williams Capital Research Comments on SCANA Corporation

Rodman & Renshaw Maintains Market Outperform, PT

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

People Also Watch

People Also Watch

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23